Search / Trial NCT06234059

Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)

Launched by UNIVERSITY OF WISCONSIN, MADISON · Jan 22, 2024

Trial Information

Current as of October 07, 2024

Not yet recruiting

Keywords

Speech Motor Control Vocal Learning

Description

The overall study (Establishing the clinical utility of sensorimotor adaptation for speech rehabilitation) aims to understand how cognitive, perceptual, and motor processes are integrated in the control of speech movements. The investigators study how this complex skill is performed in healthy speakers to understand how this system functions, how this skill relates to the perception of speech, and what role different parts of the brain play in this process. Different studies look at how speech motor control is executed, maintained, and changed. Overall, the study will recruit 329 participan...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria (Control):
  • * English-speaking adults
  • * normal hearing and speech
  • * no history of stroke or neurological conditions
  • Exclusion Criteria:
  • * Native language other than English
  • * Any neurological disorders other than the disorder of interest
  • * Any history of hearing disorders
  • * Uncorrected vision problems that prevent participants from seeing visually-presented stimuli
  • * Significant cognitive impairments that prevent participants from carrying out the task or from giving informed consent
  • * Vulnerable populations (minors and prisoners)
  • * Additional exclusionary criteria for TMS:
  • * Implanted paramagnetic materials (metal clips, plates, pacemakers, etc.)
  • * Increased risk in the event of a seizure
  • * Serious heart disease
  • * Increased intracranial pressure
  • * Pregnancy
  • * History of seizures
  • * Family history of epilepsy
  • * Epileptogenic medications
  • * Chronic or transient disruption of sleep (including jet lag)
  • * History of fainting
  • * Chronic or transient increase in stressful experiences
  • * Use of illegal drugs

About University Of Wisconsin, Madison

The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.

Locations

Madison, Wisconsin, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0